Second cancers after radiotherapy: Any evidence for radiation-induced genomic instability?

Oncogene

Volumn 22, Issue 45 REV. ISS. 5, 2003, Pages 7018-7027

  Sigurdson, Alice J ^a   Jones, Irene M ^b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b LAWRENCE LIVERMORE NATIONAL LABORATORY   (United States)

Author keywords

Chromosomal instability; Genomic instability; Radiation therapy; Review; Second primary cancer

Indexed keywords

BYSTANDER EFFECT; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CHROMOSOME ABERRATION; GENE MUTATION; GENETIC DAMAGE; GENOMICS; HUMAN; IN VIVO STUDY; NONHUMAN; PRIORITY JOURNAL; PROGENY; REVIEW; SECOND CANCER;

DNA DAMAGE; GENOMIC INSTABILITY; HUMANS; NEOPLASMS, RADIATION-INDUCED; RADIOTHERAPY; RISK FACTORS;

ANIMALIA;

EID: 0242490157     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1206989     Document Type: Review

References (61)

1. Alter BP and Young NS. (1998). Hematology of Infancy and Childhood, Vol. 1. Nathan DG and Oski FA (eds). Saunders: Philadelphia, PA, pp. 259-272.
2. Backlund MG, Trasti SL, Backlund DC, Cressman VL, Godfrey V and Koller BH. (2001). Cancer Res., 61, 6577-6582.
3. Barcellos-Hoff MH and Brooks AL. (2001). Radiat. Res., 156, 618-627.
4. Bauchinger M. (1998). Mutat. Res., 404, 89-96.
5. Behrens C, Travis LB, Wistuba II, Davis S, Maitra A, Clarke EA, Lynch CF, Glimelius B, Wiklund T, Tarone R and Gazdar AF. (2000). Cancer Epidemiol. Biomarkers Prev., 9, 1027-1035.
6. Ben-Yehuda D, Krichevsky S, Caspi O, Rund D, Polliack A, Abeliovich D, Zelig O, Yahalom V, Paltiel O, Or R, Peretz T, Ben-Neriah S, Yehuda O and Rachmilewitz EA. (1996). Blood, 88, 4296-4303.
7. Berwick M, Matullo G and Vineis P. (2002). Biomarkers of Environmentally Associated Disease: Technologies, Concepts and Perspectives. Wilson SH and Suk WA (eds). Lewis Publishers: Boca Raton, FL, pp. 84-105.
8. Berwick M and Vineis P. (2000). J. Natl. Cancer Inst., 92, 874-897.
9. Bhatia S, Robison LL, Oberlin O, Greenberg M, Bunin G, Fossati-Bellani F and Meadows AT. (1996). N. Engl. J. Med., 334, 745-751.
10. Boice Jr JD, Blettner M, Kleinerman RA, Stovall M, Moloney WC, Engholm G, Austin DF, Bosch A, Cookfair DL, Krementz ET, Latourette HB, Peters LJ, Schulz MD, Lundell M, Pettersson F, Storm HH, Bell CMJ, Coleman MP, Fraser P, Palmer M, Prior P, Choi NW, Hislp TG, Koch M, Robb D, Robson D, Spengler RF, von Fournier D, Frishchkorn R, Lochmüller H, Pompe-Kirn V, Rimpela A, KjØrstad K, Pejovic MH, Sigurdsson K, Pisani P, Kucera H and Hutchison GB. (1987). J. Natl. Cancer Inst., 79, 1295-1311.
11. Boice Jr JD, Engholm G, Kleinerman RA, Blettner M, Stovall M, Lisco H, Moloney WC, Austin DF, Bosch A, Cookfair DL, Krementz ET, Latourette HB, Merrill JA, Peters LJ, Schulz MD, Storm HH, Björkholm E, Pettersson F, Bell CMJ, Coleman MP, Fraser P, Neal FE, Prior P, Choi WN, Hislop TG, Koch M, Kreiger N, Robb D, Robson D, Thomson DH, Lochmüller H, vonFournier D, Frischkorn R, KjØrstad KK, Rimpela A, Pejovich M-H, Kirn VP, Stankusova H, Berrino F, Sigurdsson K, Hutchison GB and MacMahon B. (1988). Radiat. Res., 116, 3-55.
12. Boice Jr JD, Land CE and Preston DL. (1996). Cancer Epidemiology and Prevention, 2nd edn. Schottenfeld D and Fraumeni Jr JF (eds). Oxford University Press: New York, pp. 319-354.
13. Boivin JF, Hutchison GB, Zauber AG, Bernstein L, Davis FG, Michel RP, Zanke B, Tan CT, Fuller LM, Mauch P and Ultman JE. (1995). J. Natl. Cancer Inst., 87, 732-741.
14. Brat DJ, James CD, Jedlicka AE, Connolly DC, Chang E, Castellani RJ, Schmid M, Schiller M, Carson DA and Burger PC. (1999). Am. J. Pathol., 154, 1431-1438.
15. Chauveinc L, Dutrillaux AM, Validire P, Padoy E, Sabatier L, Courturier J and Dutrillaux B. (1999). Cancer Genet. Cytogenet., 114, 1-8.
16. Chen Z and Sandberg AA. (2002). Am. J. Med. Genet., 115, 130-141.
17. Curtis RE, Rowlings PA, Deeg HJ, Shriner DA, Socie G, Travis LB, Horowitz MM, Witherspoon RP, Hoover RN, Sobocinski KA, Fraumeni Jr JF and Boice Jr JD. (1997). N. Engl. J. Med., 336, 897-904.
18. De Benedetti VMG, Travis LB, Welsh JA, van Leeuwen FE, Stovall M, Clarke EA, Boice Jr JD and Bennett WP. (1996). Cancer Epidemiol. Biomarkers Prev., 5, 93-98.
19. Deeg HJ, Socie G, Schoch G, Henry-Amar M, Witherspoon RP, Devergie A, Sullivan KM, Gluckman E and Storb R. (1996). Blood, 87, 386-392.
20. De Vathaire F, Hardiman C, Shamsaldin A, Campbell S, Grimaud E, Hawkins M, Raquin M, Oberlin O, Diallo I, Zucker JM, Panis X, Lagrange JL, Daly-Schveitzer N, Lemerle J, Chavaudra J, Schlumberger M and Bonaiti C. (1999). Arch. Intern. Med., 159, 2713-2719.
21. Dores GM, Metayer C, Curtis RE, Lynch CF, Clarke EA, Glimelius B, Storm H, Pukkala E, van Leeuwen FE, Holowaty EJ, Andersson M, Wiklund T, Joensuu T, van't Veer MB, Stovall M, Gospodarowicz M and Travis LB. (2002). J. Clin. Oncol., 20, 3484-3494.
22. Fang NY, Greiner TC, Weisenburger DD, Chan WC, Vose JM, Smith LM, Armitage JO, Mayer RA, Pike BL, Collins FS and Hacia JG. (2003). Proc. Natl. Acad. Sci. USA, 100, 5372-5377.
23. Ferguson DO and Alt FW. (2001). Oncogene, 20, 5572-5579.
24. Finnon P, Moquet JE, Edwards AA and Lloyd DC. (1999). Int. J. Radiat. Biol., 75, 1215-1222.
25. Friedberg EC and Meira LB. (2003). DNA Repair, 2, 501-530.
26. Gafanovich A, Ramu N, Krichevsky S, Pe'er S, Amir G and Ben-Yehuda D. (1999). Cancer, 85, 504-510.
27. Gilbert ES, Stovall M, Gospodarowicz M, van Leeuwen FE, Andersson M, Glimelius B, Joensuu T, Lynch CF, Curtis RE, Holowaty E, Storm H, Pukkala E, van't Veer MD, Fraumeni Jr JF, Boice Jr JD, Clarke EA and Travis LB. (2003). Radiat. Res., 159, 161-173.
28. Goodman MF. (2002). Annu. Rev. Biochem., 71, 17-50.
29. Gray JW and Collins C. (2000). Carcinogenesis, 21, 443-452.
30. Horiike S, Misawa S, Kaneko H, Sasai Y, Kobayashi M, Fujii H, Tanaka S, Yagita M, Abe T, Kashima K and Taniwaki M. (1999). Leukemia, 13, 1235-1242.
31. Inskip PD. (1999). Multiple Primary Cancers. Neugut AI, Meadows AT and Robinson E (eds). Lippincott Williams and Wilkins: Philadelphia, pp. 91-135.
32. Kaldor JM, Day NE, Bell J, Clarke EA, Langmark F, Karjalainen S, Band P, Pedersen D, Choi W, Blair V, Henry-Amar M, Prior P, Assouline D, Pompe-Kirn V, Cartwright RA, Koch M, Arslan A, Fraser P, Sutcliffe SB, Host H, Hakama M and Stovall M. (1992). Int. J. Cancer, 52, 677-681.
33. Kleinerman RA, Littlefield LG, Tarone RE, Sayer AM, Hildreth NG, Pottern LM, Machado SG and Boice Jr JD. (1990). Radiat. Res., 123, 93-101.
34. Kodama Y, Pawel D, Nakamura N, Preston D, Honda T, Itoh M, Nakano MK, Ohtaki K, Funamoto S and Awa AA. (2001). Radiat. Res., 156, 337-346.
35. Lefevre S-H, Bogt N, Dutrillaux A-M, Chauveinc L, Stoppa-Lyonnet D, Doz F, Desjardins L, Dutrillaux B, Chevillard S and Malfoy B. (2001). Oncogene, 20, 8092-8099.
36. Lindahl T. (1993). Nature, 362, 709-715.
37. Little JB. (2000). Carcinogenesis, 21, 397-404.
38. Loeb LA, Loeb KR and Anderson JP. (2003). Proc. Natl. Acad. Sci. USA, 100, 776-781.
39. Lorimore SA and Wright EG. (2003). Int. J. Radiat. Biol., 79, 15-25.
40. Mendelsohn ML. (1995). Modeling of Biological Effects and Risks of Radiation Exposure. Inaba J and Kobayashi S (eds). National Institute of Radiological Sciences: Chiba, Japan, pp. 185-192.
41. Mertens F, Larramendy ML, Gustavsson A, Gisselsson D, Rydholm A, Brosjo O, Mitelman F, Knuutila YS and Mandahl N. (2000). Cancer Genet. Cytogenet., 116, 89-96.
42. Mohrenweiser HW, Wilson III DM and Jones IM. (2003). Mutat. Res., 526, 93-125.
43. Morgan WF. (2003a). Radiat. Res., 159, 567-580.
44. Morgan WF. (2003b). Radiat. Res., 159, 581-596.
45. Platz EA, Wiencke JK, Kelsey KT, Janower ML, Schottenfeld D, Travis LB and Goldman MB. (2000). Int. J. Radiat. Biol., 76, 955-961.
46. Robison LL, Mertens AC, Boice JD, Breslow NE, Donaldson SS, Green DM, Li FP, Meadows AT, Mulvihill JJ, Neglia JP, Nesbit ME, Paker RJ, Potter JD, Sklar CA, Smith MA, Stovall M, Strong LC, Yasui Y and Zeltzer LK. (2002). Med. Pediatr. Oncol., 38, 229-239.
47. Ronen A and Glickman BW. (2001). Environ. Mol. Mutagen., 37, 241-283.
48. Shoshan Y, Chernova O, Jeun S-S, Somerville RP, Israel Z, Barnett GH and Cowell JK. (2000). J. Neuropathol. Exp. Neurol., 59, 614-620.
49. Swerdlow AJ, Douglas AJ, Vaughn Hudson G, Vaughan Hudson B, Bennett MH and MacLennan KA. (1992). BMJ, 304, 1137-1143.
50. Tarkkanen M, Wiklund TA, Virolainen MJ, Larramendy ML, Mandahl N, Mertens F, Blomqvist CP, Tukiainen EJ, Miettinen MMA, Elomaa AI and Knuutila YS. (2001). Cancer, 92, 1992-1998.
51. Travis LB, Gospodarowicz M, Curtis RE, Clarke EA, Andersson M, Glimelius B, Joensuu T, Lynch CF, van Leeuwen FE, Holowaty E, Storm H, Glimelius I, Pukkala E, Stovall M, Fraumeni Jr JF, Boice Jr JD and Gilbert E. (2002). J. Natl. Cancer Inst., 94, 182-192.
52. Travis LB, Andersson M, Gospodarowicz M, van Leeuwen FE, Bergfeldt K, Lynch CF, Curtis RE, Kohler BA, Wiklund T, Storm H, Holowaty E, Hall P, Pukkala E, Sleijfer DT, Clarke EA, Boice Jr JD, Stovall M and Gilbert E. (2000). J. Natl. Cancer Inst., 92, 1165-1171.
53. Tucker MA, Coleman CN, Cox RS, Barghese A and Rosenberg SA. (1988). N. Engl. J. Med., 318, 76-81.
54. Tucker MA, Morris Jones PH, Boice Jr JD, Robison LL, Stone BJ, Stovall M, Jenkin RDT, Lubin JH, Baum ES, Siegel SE, Meadows AT, Hoover RN and Fraumeni Jr JF. (1991). Cancer Res., 51, 2885-2888.
55. Tucker JD, Ramsey MJ, Lee DA and Minkler JL. (1993). Int. J. Radiat. Biol., 64, 27-37.
56. Ullrich RL and Ponnaiya B. (1998). Int. J. Radiat. Biol., 74, 747-754.
57. van Leeuwen FE, Klokman WJ, Hagenbeek A, Noyon R, van den Belt-Dusebout AW, van Kerkhoff EH, van Heerde P and Somers R. (1994). J. Clin. Oncol., 12, 312-325.
58. Wood RD, Mitchell M, Sgouros J and Lindahl T. (2001). Science, 291, 1284-1289 (Current supplement at http://www.cgal.icnet.uk/DNA_Repair_Genes.html) .
59. Wright EG. (1999). J. Pathol., 187, 19-27.
60. Yu Y, Okayasu R, Weil MM, Silver A, McCarthy M, Zabriskie R, Long S, Cox R and Ullrich RL. (2001). Cancer Res., 61, 1820-1824.
61. Zablotska LB and Neugut AI. (2003). Cancer, 97, 1404-1411.